Funder
National Nature Science Foundation of China
Shanghai Science and Technology Commission Research Project
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference61 articles.
1. Hsing AW, Sakoda LC, Rashid A, Chen J, Shen MC, Han TQ, Wang BS, Gao YT (2008) Body size and the risk of biliary tract cancer: a population-based study in China. Br J Cancer 99(5):811–815
2. Hsing AW, Bai Y, Andreotti G, Rashid A, Deng J, Chen JB, Goldstein AM, Han TQ, Shen MC, Fraumeni JF et al (2007) Family history of gallstones and the risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Int J Cancer 121(4):832–838
3. Wernberg JA, Lucarelli DD (2014) Gallbladder cancer. Surg Clin N Am 94(2):343–360
4. Zheng YH, Xu DY, Bu ZD (2016) Chinese version of NCCN clinical practice guidelines in oncology officially authorized by NCCN. Chin J Cancer Res 28(1):144–145
5. Pedersen KS, Kim GP, Foster NR, Wang-Gillam A, Erlichman C, McWilliams RR (2015) Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study. Investig New Drugs 33(4):963–968
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献